126 related articles for article (PubMed ID: 2010310)
1. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
[No Abstract] [Full Text] [Related]
2. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
[TBL] [Abstract][Full Text] [Related]
3. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
4. [Immunoscintigraphy of oncologic tumors].
Barzen G
Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
6. [REGAJ diagnosis of recurrence of ovarian cancer].
Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
[No Abstract] [Full Text] [Related]
7. Clinical value of radioimmunoscintigraphy in the follow-up of ovarian carcinoma: a prospective study.
Crippa F; Presti M; Marini A; D'Onofrio B; Bolis G; Buraggi GL
Int J Biol Markers; 1990; 5(3):103-8. PubMed ID: 2286774
[TBL] [Abstract][Full Text] [Related]
8. [Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].
Barzen G; Cordes M; Langer M; Friedman W; Mayr AC; Felix R
Rofo; 1990 Jul; 153(1):85-91. PubMed ID: 2166319
[TBL] [Abstract][Full Text] [Related]
9. [The place of radioimmunoscintigraphy in the diagnosis and follow-up of ovarian cancer in comparison with computed tomography and second-look surgery].
Barzen G; Friedmann W; Richter W; Schönegg W; Riess H; Eichstädt H; Lichtenegger W; Felix R
Nuklearmedizin; 1992 Feb; 31(1):16-23. PubMed ID: 1561116
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of RIS with the 131I-OC 125 F(ab')2 Mab and CT scan prior to second look operation for ovarian cancer.
Papazefkos V; Michalas S; Papantoniou V; Datseris J; Athanasiadis P; Akrivos T; Leonti A; Xygakis A; Aravantinos D
Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):271-7. PubMed ID: 2227070
[TBL] [Abstract][Full Text] [Related]
11. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.
Granowska M; Britton KE; Shepherd JH; Nimmon CC; Mather S; Ward B; Osborne RJ; Slevin ML
J Clin Oncol; 1986 May; 4(5):730-6. PubMed ID: 3701391
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
[TBL] [Abstract][Full Text] [Related]
14. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy of ovarian cancer.
Granowska M; Britton KE
Dis Markers; 1991; 9(3-4):191-5. PubMed ID: 1725973
[No Abstract] [Full Text] [Related]
16. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.
Brökelmann J; Bockisch A; Vogel J; Reinsberg J; Oehr P; Biersack HJ; Krebs D
Arch Gynecol Obstet; 1989; 244(4):193-206. PubMed ID: 2782949
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
[TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy in the follow up of patients with ovarian cancer.
Gerli M; Palumbo R; Angelini A; Gerli S; Brunelli E; Pupita P; Bonaca S; Spagnolo W
Eur J Gynaecol Oncol; 1990; 11(3):203-4. PubMed ID: 2209638
[TBL] [Abstract][Full Text] [Related]
19. 123I radioiodinated antibody imaging of occult ovarian cancer.
Epenetos AA; Shepherd J; Britton KE; Mather S; Taylor-Papadimitriou J; Granowska M; Durbin H; Nimmon CC; Hawkins LR; Malpas JS
Cancer; 1985 Mar; 55(5):984-7. PubMed ID: 3881163
[TBL] [Abstract][Full Text] [Related]
20. Role of 131I-labelled anti-CEA/CA 19-9 monoclonal antibodies in the diagnosis and follow-up of gastrointestinal tumors.
Giordano A; Rufini V; Campioni P; Vaccaro A; Troncone L
Int J Rad Appl Instrum B; 1989; 16(2):151. PubMed ID: 2715009
[No Abstract] [Full Text] [Related]
[Next] [New Search]